Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study
- PMID: 33013699
- PMCID: PMC7505923
- DOI: 10.3389/fendo.2020.00621
Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study
Abstract
Background: Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder that is influenced by both genetic and environmental factors. However, the etiology of PCOS remains unclear. Methods: We conducted a two-sample Mendelian randomization (MR) analysis to assess the causal effects of genetically determined metabolites (GDMs) on the risk of PCOS. We used summary level data of a genome-wide association study (GWAS) on 486 metabolites (n = 7,824) as exposure and a PCOS GWAS consisting of 4,138 cases and 20,129 controls as the outcome. Both datasets were obtained from publicly published databases. For each metabolite, a genetic instrumental variable was generated to assess the relationship between the metabolite and PCOS. For MR analysis, we primarily used the standard inverse variance weighted (IVW) method, while three additional methods-the MR-Egger, weighted median, and MR-PRESSO (pleiotropy residual sum and outlier) methods-were performed as sensitivity analyses. Results: Using genetic variants as predictors, we observed a robust relationship between epiandrosterone sulfate (EPIA-S) and PCOS (PIVW = 0.0186, PMR-Egger = 0.0111; PWeighted-median = 0.0154, and PMR-PRESSO = 0.0290). Similarly, 3-dehydrocarnitine, 4-hydroxyhippurate, hexadecanedioate, and β-hydroxyisovalerate may also have causal effects on PCOS development. Conclusions: We identified metabolites that might have causal effects on PCOS development. Our study emphasizes the role of genetic factors underlying the causal relationships between metabolites and PCOS and provides novel insights through the integration of metabolomics and genomics to better understand the mechanisms involved in human disease pathogenesis.
Keywords: epiandrosterone sulfate; genetically determined metabolites; mendelian randomization; polycystic ovary syndrome; rs13222543.
Copyright © 2020 Sun, Jiao, Han, Zhang, Shi, Shi and Li.
Figures
Similar articles
-
A metabolome-wide Mendelian randomization study prioritizes causal circulating metabolites for reproductive disorders including primary ovarian insufficiency, polycystic ovary syndrome, and abnormal spermatozoa.J Ovarian Res. 2024 Aug 14;17(1):166. doi: 10.1186/s13048-024-01486-1. J Ovarian Res. 2024. PMID: 39143642 Free PMC article.
-
Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study.J Transl Med. 2022 Oct 20;20(1):475. doi: 10.1186/s12967-022-03691-2. J Transl Med. 2022. PMID: 36266699 Free PMC article.
-
Genetic insights of blood lipid metabolites on polycystic ovary syndrome risk: a bidirectional two-sample Mendelian randomization study.Front Endocrinol (Lausanne). 2024 Jul 9;15:1391826. doi: 10.3389/fendo.2024.1391826. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39045272 Free PMC article.
-
Causal relationship between gut microbiota and polycystic ovary syndrome: a literature review and Mendelian randomization study.Front Endocrinol (Lausanne). 2024 Feb 1;15:1280983. doi: 10.3389/fendo.2024.1280983. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38362275 Free PMC article. Review.
-
Causes and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization.J Clin Endocrinol Metab. 2022 Feb 17;107(3):e899-e911. doi: 10.1210/clinem/dgab757. J Clin Endocrinol Metab. 2022. PMID: 34669940 Free PMC article. Review.
Cited by
-
Investigating the relationship between blood metabolites and diabetic retinopathy using two-sample mendelian randomization and in vivo validation.Sci Rep. 2024 Oct 3;14(1):22947. doi: 10.1038/s41598-024-73337-4. Sci Rep. 2024. PMID: 39362968 Free PMC article.
-
Genetic liability to human serum metabolites is causally linked to telomere length: insights from genome-wide Mendelian randomization and metabolic pathways analysis.Front Nutr. 2024 Aug 26;11:1458442. doi: 10.3389/fnut.2024.1458442. eCollection 2024. Front Nutr. 2024. PMID: 39253325 Free PMC article.
-
Potential Causal Association between Plasma Metabolites, Immunophenotypes, and Female Reproductive Disorders: A Two-Sample Mendelian Randomization Analysis.Biomolecules. 2024 Jan 16;14(1):116. doi: 10.3390/biom14010116. Biomolecules. 2024. PMID: 38254716 Free PMC article.
-
Heme oxygenase 2 genetic variants alter hormonal and metabolic traits in polycystic ovary syndrome.Endocr Connect. 2024 Feb 12;13(3):e230463. doi: 10.1530/EC-23-0463. Print 2024 Mar 1. Endocr Connect. 2024. PMID: 38251965 Free PMC article.
-
Causality Investigation between Gut Microbiota, Derived Metabolites, and Obstructive Sleep Apnea: A Bidirectional Mendelian Randomization Study.Nutrients. 2023 Oct 26;15(21):4544. doi: 10.3390/nu15214544. Nutrients. 2023. PMID: 37960197 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical